Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction.
作者信息
Mogensen C E
出版信息
BMJ. 1998 Sep 12;317(7160):693-4. doi: 10.1136/bmj.317.7160.693.
Abstract
摘要
相似文献
1
Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction.2型糖尿病合并高血压和高血糖：双重风险。英国的试验显示了治疗的显著效果，尤其是血压降低。
BMJ. 1998 Sep 12;317(7160):693-4. doi: 10.1136/bmj.317.7160.693.
2
Renoprotection with antihypertensive agents.
Lancet. 2002 May 11;359(9318):1693; author reply 1693-4. doi: 10.1016/s0140-6736(02)08564-1.
3
Follow-up of intensive glucose control in type 2 diabetes.
N Engl J Med. 2009 Jan 22;360(4):417-8; author reply 418.
4
Managing cardiovascular risk in patients with diabetes.控制糖尿病患者的心血管疾病风险。
Heart. 2000 Sep;84 Suppl 1(Suppl 1):i23-5:discussion i50. doi: 10.1136/heart.84.suppl_1.i23.
5
Antihypertensive therapy in type 2 diabetes mellitus.
J Fam Pract. 1998 Dec;47(6):413-4.
6
[Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].
Dtsch Med Wochenschr. 2007 Nov;132(44):2330-1. doi: 10.1055/s-2007-991652.
7
[Focus on intensive therapeutic strategy in type 2-diabetes].[聚焦2型糖尿病的强化治疗策略]
Ugeskr Laeger. 1998 Sep 14;160(38):5469-70.
8
A review of chemical therapies for treating diabetic hypertension.治疗糖尿病性高血压的化学疗法综述。
Expert Opin Pharmacother. 2017 Jun;18(9):909-923. doi: 10.1080/14656566.2017.1328054. Epub 2017 May 16.
9
[Treatment of hypertension in patients with adult-onset diabetes].
Duodecim. 1999;115(10):1147-53.
10
[Which antihypertensive therapy is indicated in type 2 diabetic patients?].
Dtsch Med Wochenschr. 2002 Jul 12;127(28-29):1543-4. doi: 10.1055/s-2002-32753.
引用本文的文献
1
Digital Twin in Managing Hypertension Among People With Type 2 Diabetes: 1-Year Randomized Controlled Trial.数字孪生技术在2型糖尿病患者高血压管理中的应用：一项为期1年的随机对照试验。
JACC Adv. 2024 Aug 14;3(9):101172. doi: 10.1016/j.jacadv.2024.101172. eCollection 2024 Sep.
2
Novel Insights into Diabetic Kidney Disease.糖尿病肾病的新见解。
Int J Mol Sci. 2024 Sep 23;25(18):10222. doi: 10.3390/ijms251810222.
3
Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study.血压监测作为改善糖尿病临床结局的数字健康工具：回顾性真实世界研究
J Med Internet Res. 2022 Feb 8;24(2):e32923. doi: 10.2196/32923.
4
Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from Glycemia Control: Comparison to Vildagliptin.二甲双胍可改善糖尿病自发性高血压大鼠的内皮功能并降低血压，与控制血糖无关：与维格列汀的比较。
Sci Rep. 2017 Sep 8;7(1):10975. doi: 10.1038/s41598-017-11430-7.
5
Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus.SLC12A3 基因 Arg913Gln 促进中国 2 型糖尿病终末期肾病的发生发展。
Mol Cell Biochem. 2018 Jan;437(1-2):203-210. doi: 10.1007/s11010-017-3120-z. Epub 2017 Jul 25.
6
Renal disease pathophysiology and treatment: contributions from the rat.肾脏疾病的病理生理学与治疗：大鼠研究的贡献
Dis Model Mech. 2016 Dec 1;9(12):1419-1433. doi: 10.1242/dmm.027276.
7
The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.血管紧张素转换酶基因I/D变异增加接受血液透析的中国2型糖尿病患者发生终末期肾病的风险。
Mol Cell Biochem. 2016 Nov;422(1-2):181-188. doi: 10.1007/s11010-016-2819-6. Epub 2016 Sep 16.
8
An Update on the Use of Animal Models in Diabetic Nephropathy Research.糖尿病肾病研究中动物模型应用的最新进展
Curr Diab Rep. 2016 Feb;16(2):18. doi: 10.1007/s11892-015-0706-2.
9
Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes Mellitus.代谢综合征和糖尿病的标准及新型治疗方案
Curr Treat Options Cardiovasc Med. 2015;15:706-721. doi: 10.1007/s11936-013-0273-2. Epub 2013 Nov 15.
10
Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.高血糖和肾素依赖性高血压协同作用模拟糖尿病肾病。
J Am Soc Nephrol. 2012 Mar;23(3):405-11. doi: 10.1681/ASN.2011060577. Epub 2011 Dec 22.
本文引用的文献
1
2
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
3
4
5
6
Cardiovascular risk continuum: implications of insulin resistance and diabetes.心血管风险连续体：胰岛素抵抗和糖尿病的影响
Am J Med. 1998 Jul 6;105(1A):4S-14S. doi: 10.1016/s0002-9343(98)00205-8.
7
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.糖尿病及其并发症的定义、诊断和分类。第1部分：糖尿病的诊断和分类——世界卫生组织咨询会议临时报告
Diabet Med. 1998 Jul;15(7):539-53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
8
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.强化降压与小剂量阿司匹林对高血压患者的影响：高血压最佳治疗（HOT）随机试验的主要结果。HOT研究组
Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6.
9
Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide.钙通道阻滞剂。它们是否会引发心脏病和自杀，尚无定论。
BMJ. 1998 May 16;316(7143):1471-3. doi: 10.1136/bmj.316.7143.1471.
10
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23).非胰岛素依赖型糖尿病患者冠状动脉疾病的危险因素：英国前瞻性糖尿病研究（UKPDS：23）
BMJ. 1998 Mar 14;316(7134):823-8. doi: 10.1136/bmj.316.7134.823.
Zotero 插件